Page last updated: 2024-10-29

iomeprol and Leukoaraiosis

iomeprol has been researched along with Leukoaraiosis in 1 studies

iomeprol: structure given in first source
iomeprol : A benzenedicarboxamide compound having N-substituted carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and a glycoloyl(methyl)amino group at the 5-position.

Leukoaraiosis: Non-specific white matter changes in the BRAIN, often seen after age 65. Changes include loss of AXONS; MYELIN pallor, GLIOSIS, loss of ependymal cells, and enlarged perivascular spaces. Leukoaraiosis is a risk factor for DEMENTIA and CEREBROVASCULAR DISORDERS.

Research Excerpts

ExcerptRelevanceReference
"Patients with leukoaraiosis have a negative prognosis in terms of death, stroke, and myocardial infarction."1.35Carotid artery abnormalities and leukoaraiosis in elderly patients: evaluation with MDCT. ( Mallarini, G; Montisci, R; Pascalis, L; Saba, L; Sanfilippo, R, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Saba, L1
Sanfilippo, R1
Pascalis, L1
Montisci, R1
Mallarini, G1

Other Studies

1 other study available for iomeprol and Leukoaraiosis

ArticleYear
Carotid artery abnormalities and leukoaraiosis in elderly patients: evaluation with MDCT.
    AJR. American journal of roentgenology, 2009, Volume: 192, Issue:2

    Topics: Aged; Aged, 80 and over; Carotid Stenosis; Chi-Square Distribution; Contrast Media; Female; Humans;

2009